同型半胱氨酸糖化血红蛋白神经胶质纤维酸性蛋白在急性缺血性卒患者中的表达及意义

doi:10.3969/j.issn.1006-6233.2018.08.008

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1341 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的: 探讨同型半胱氨酸(Hcy)、糖化血红蛋白(HbAlc)、神经胶质纤维酸性蛋白(GFAP)在急性缺血性卒中患者中的表达及意义。 方法: 选择2015年10月至2016年10月我院接诊的急性缺血性卒中患者80例,作为观察组,并选择同期我院接诊的健康体检人群80例,作为对照组。使用酶联免疫吸附法(ELISA)检测所有受试者Hcy、HbAlc、GFAP的表达,并比较不同梗死程度、不同病情严重程度、不同预后急性缺血性卒中患者Hcy、HbAlc、GFAP的表达,分析Hcy、HbAlc、GFAP和急性缺血性卒中的关系。 结果: 观察组Hcy、HbAlc、GFAP均明显高于对照组(P<0.05);随着患者梗死面积的增加、病情严重程度的增加,Hcy、HbAlc、GFAP的表达也随之增加,比较均具有显著差异(P<0.05);预后不良组患者Hcy、HbAlc、GFAP明显高于预后良好组(P<0.05);经Pearson相关分析显示,Hcy、HbAlc、GFAP和美国国立卫生研究院卒中量表(NIHSS)评分、脑梗死面积之间均呈正相关(P<0.05);且在Logistic回归中显示,Hcy、HbAlc、GFAP均是影响急性缺血性卒中患者预后的危险因素(P<0.05)。 结论: Hcy、HbAlc、GFAP均是影响急性缺血性卒中神经功能缺损程度和预后的独立危险因素,可作为诊断、治疗、评估病情的重要指标,临床应用价值高。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张楠
	贾永花
	冀旗玲
	杜会山

关键词 ：急性缺血性卒中, 神经功能, 同型半胱氨酸, 糖化血红蛋白, 神经胶质纤维酸性蛋白

Abstract：Objective: To study the expression and significance of homocysteine (Hcy), glycosylated hemoglobin (HbAlc), glial fibrillary acidic protein (GFAP) in acute ischemic stroke patients. Methods: 80 patients of acute ischemic stroke received therapy from Oct. 2015 to Oct. 2016 in our hospital were selected as observation group, in the same period, 80 healthy people who received medical examination in our hospital were selected as the control group. Enzyme linked immunosorbent assay (ELISA) was used to detect the expression of Hcy, HbAlc and GFAP in all subjects, the expression of Hcy, HbAlc and GFAP in patients with acute ischemic stroke with different infarct level, different severity of disease and different prognosis were compared, and the relationship between Hcy, HbAlc, GFAP and acute ischemic stroke was analyzed. Results: The Hcy, HbAlc and GFAP in the observation group were significantly higher than those in the control group (P<0.05); the expression of Hcy, HbAlc and GFAP increased with the increase of infarct size and the severity of the disease, and the difference was significantly different (P<0.05); the Hcy, HbAlc and GFAP in the poor prognosis group were significantly higher than those in the good prognosis group (P<0.05); the Pearson correlation analysis showed that there was a positive correlation between Hcy, HbAlc, GFAP and the degree of National Institutes of Health Stroke Scale (NIHSS) scores and the area of cerebral infarction (P<0.05); and in Logistic regression, Hcy, HbAlc, and GFAP are all risk factors affecting the prognosis of patients with acute ischemic stroke (P<0.05). Conclusion: Hcy, HbAlc and GFAP are independent risk factors that affect the degree and prognosis of acute ischemic stroke, it can be used as an important indicator of diagnosis, treatment and evaluation of the disease, and it is of high value in clinical application.

Key words： Acute ischemic stroke Nerve function Homocysteine Glycosylated hemoglobin Glial fibrillary acidic protein

基金资助:北京市自然科学基金项目,(编号:2011K057)

通讯作者: 杜会山

引用本文:

张楠, 贾永花, 冀旗玲, 杜会山. 同型半胱氨酸糖化血红蛋白神经胶质纤维酸性蛋白在急性缺血性卒患者中的表达及意义[J]. 河北医学, 2018, 24(8): 1261-1265.
ZHANG Nan, JIA Yonghua, JI Qiling, et al. Expression and Significance of Homocysteine Glycosylated Hemoglobin and Glial Fibrillary Acidic Protein in Patients with Acute Ischemic Stroke. HeBei Med, 2018, 24(8): 1261-1265.

链接本文:

http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2018.08.008 或 http://www.hbyxzzs.cn/CN/Y2018/V24/I8/1261

[1] 曹承兰,余年,林兴建,等.脑卒中高危人群的相关危险因素[J].临床神经病学杂志,2014,27(5):335~337.
[2] Banecka-Majkutewicz Z, Kadziński L, Grabowski M, et al. Evidence for interactions between homocysteine and genistein: insights into stroke risk and potential treatment[J]. Metab Brain Dis, 2017, 32(6): 1855~1860.
[3] Olaiya MT, Cadilhac DA, Kim J, et al. Community-based intervention to improve cardiometabolic targets in patients with stroke: a randomized controlled trial[J]. Stroke, 2017, 48(9): 2504~2510.
[4] 倪亚珺,叶志弘.中国人群2型糖尿病患者并发脑卒中危险因素的Meta分析[J].护理与康复,2016,15(11):1026~1033.
[5] Vietheer JM, Rieger J, Wagner M, et al. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma[J].Neurooncol, 2017, 135(1): 193~199.
[6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246~257.
[7] 蔡业峰,贾真,张新春,等.美国国立卫生院卒中量表(NIHSS)中文版多中心测评研究--附537例缺血中风多中心多时点临床测评研究[J].北京中医药大学学报,2008,31(7):494~498.
[8] McArthur K, Fan Y, Pei Z, et al. Optimising outcome assessment to improve quality and efficiency of stroke trials[J]. Expert Rev Pharmacoecon. Outcomes Res, 2014, 14(1): 101~111
[9] 王萍,韩耀风,赵天予,等.中国人群脑卒中发病影响因素Meta分析[J].现代预防医学,2016,43(16):2893~2896.
[10] Cloonan L, Fitzpatrick KM, Kanakis AS, et al. Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke[J]. Atherosclerosis, 2015, 240(1): 149~153.
[11] Lehmann MF, Kallaur AP, Oliveira SR, et al. Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes[J]. Metab Brain Dis, 2015, 30(6): 1417~1428.
[12] Shin SB, Kim TU, Hyun JK, et al. The Prediction of Clinical Outcome Using HbA1c in Acute Ischemic Stroke of the Deep Branch of Middle Cerebral Artery[J]. Ann Rehabil Med, 2015, 39(6): 1011~1017.
[13] 郭双喜,马安娜,史莉瑾.糖化血红蛋白水平与急性缺血性脑卒中患者神经功能缺损及预后的关系[J].山东医药,2014,54(8):32~34.
[14] Dos Santos JPA, Vizuete A, Hansen F, et al. Early and persistent o-GlcNAc protein modification in the streptozotocin model of alzheimer's disease[J].Alzheimers Dis, 2018, 61(1): 237~249.
[15] Zhang J, Zhang CH, Lin XL, et al. Serum glial fibrillary acidic protein as a biomarker for differentiating intracerebral hemorrhage and ischemic stroke in patients with symptoms of acute stroke: a systematic review and meta-analysis[J]. Neurol Sci, 2013, 34(11): 1887~1892.